Properdin

Properdin

Properdin 詳細

Molecule Name
Properdin
分子の別称
Properdin,Complement factor P,CFP,PFC
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Complement factor P,CFP
バックグランド
Properdin is also known as Complement factor P, CFP, PFC, a positive regulator of the alternate pathway of complement. It binds to and stabilizes the C3- and C5-convertase enzyme complexes. Properdin is produced by many different leukocyte subsets and circulates as cyclic oligomers of monomeric subunits. Properdin on platelet/granulocyte aggregates(PGA) formation are tightly regulated by Factor H, properdin enhances PGA formation via increased production of C5a, and that inhibition of properdin function has therapeutic potential to limit thromboinflammation in diseases characterized by increased PGA formation.

Properdin 製品リスト

Species
  • Human(1)
  • Mouse(1)
  • Rhesus macaque(1)
Tag
  • His Tag(3)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(3)
Grade
  • RUO(3)
Low Endotoxin
  • No(3)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
Properdin
Human Properdin Protein, His Tag
Human
HEK293
SDS-PAGE

$360.00

100ug
Properdin
Mouse Properdin Protein, His Tag
Mouse
HEK293
SDS-PAGE

$360.00

100ug
Properdin
Rhesus macaque Properdin Protein, His Tag
Rhesus macaque
HEK293
SDS-PAGE

$360.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
TarperprumigALXN-1820Phase 2 ClinicalAlexion Pharmaceuticals Inc
Anemia, Sickle Cell; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
詳細
NM-5072NM5072; NM-5072Phase 1 ClinicalNovelMed Therapeutics Inc
Atypical Hemolytic Uremic Syndrome; Eye Diseases; Hemoglobinuria, Paroxysmal
詳細
Customer Reviews